AKT1 and osteosarcoma: In addition, enhanced WTAP activity can lead to m6A methylation and degradation of HMBOX1 mRNA, an activator of PI3K-AKT pathway, which also in turn inhibits excessive proliferation of osteoblasts towards osteosarcoma [140].